Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

A population-based study of cardiac morbidity among Hodgkin lymphoma patients with preexisting heart disease.

Myrehaug S, Pintilie M, Yun L, Crump M, Tsang RW, Meyer RM, Sussman J, Yu E, Hodgson DC.

Blood. 2010 Sep 30;116(13):2237-40. doi: 10.1182/blood-2010-01-263764. Epub 2010 Jul 1.

2.

Cardiac morbidity following modern treatment for Hodgkin lymphoma: supra-additive cardiotoxicity of doxorubicin and radiation therapy.

Myrehaug S, Pintilie M, Tsang R, Mackenzie R, Crump M, Chen Z, Sun A, Hodgson DC.

Leuk Lymphoma. 2008 Aug;49(8):1486-93. doi: 10.1080/10428190802140873.

PMID:
18608873
3.

Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma.

De Bruin ML, Dorresteijn LD, van't Veer MB, Krol AD, van der Pal HJ, Kappelle AC, Boogerd W, Aleman BM, van Leeuwen FE.

J Natl Cancer Inst. 2009 Jul 1;101(13):928-37. doi: 10.1093/jnci/djp147. Epub 2009 Jun 17.

PMID:
19535773
4.

Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation.

Galper SL, Yu JB, Mauch PM, Strasser JF, Silver B, Lacasce A, Marcus KJ, Stevenson MA, Chen MH, Ng AK.

Blood. 2011 Jan 13;117(2):412-8. doi: 10.1182/blood-2010-06-291328. Epub 2010 Sep 21.

5.

Cardiac risk after mediastinal irradiation for Hodgkin's disease.

Glanzmann C, Kaufmann P, Jenni R, Hess OM, Huguenin P.

Radiother Oncol. 1998 Jan;46(1):51-62.

PMID:
9488128
6.
7.

[Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].

Niu Y, Shi YK, He XH, Feng FY, Zhou LQ, Gu DZ.

Zhonghua Zhong Liu Za Zhi. 2008 Aug;30(8):630-4. Chinese.

PMID:
19102946
8.

Clinical dose-volume histogram analysis in predicting radiation pneumonitis in Hodgkin's lymphoma.

Koh ES, Sun A, Tran TH, Tsang R, Pintilie M, Hodgson DC, Wells W, Heaton R, Gospodarowicz MK.

Int J Radiat Oncol Biol Phys. 2006 Sep 1;66(1):223-8.

PMID:
16904523
9.
10.

Late cardiac toxicity secondary to treatment in Hodgkin's disease. A study comparing doxorubicin, epirubicin and mitoxantrone in combined therapy.

Avilés A, Neri N, Nambo JM, Huerta-Guzman J, Talavera A, Cleto S.

Leuk Lymphoma. 2005 Jul;46(7):1023-8.

PMID:
16019553
11.

Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin's lymphoma.

Hershman DL, McBride RB, Eisenberger A, Tsai WY, Grann VR, Jacobson JS.

J Clin Oncol. 2008 Jul 1;26(19):3159-65. doi: 10.1200/JCO.2007.14.1242.

PMID:
18591554
12.

[Effect of high-dose chemotherapy with subsequent transplantation of blood-forming cells on left ventricle function in patients with malignant lymphomas treated with doxorubicin in primary chemotherapy].

Elbl L, Vásová I, Krejcí M, Navrátil M, Tomásková I, Jedlicka F, Chaloupka V, Mayer J, Vorlícek J.

Vnitr Lek. 2006 Mar;52(3):221-31. Czech.

PMID:
16722153
14.
15.

[Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].

Fu XH, Wang SS, Huang Y, Wang B, Huang HQ, Zhang L, Sun XF, Xu RH, Lin TY.

Ai Zheng. 2006 Aug;25(8):1013-8. Chinese.

PMID:
16965685
16.

Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors.

Ng AK, Bernardo MV, Weller E, Backstrand K, Silver B, Marcus KC, Tarbell NJ, Stevenson MA, Friedberg JW, Mauch PM.

Blood. 2002 Sep 15;100(6):1989-96.

17.

Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults.

Hequet O, Le QH, Moullet I, Pauli E, Salles G, Espinouse D, Dumontet C, Thieblemont C, Arnaud P, Antal D, Bouafia F, Coiffier B.

J Clin Oncol. 2004 May 15;22(10):1864-71.

PMID:
15143078
18.

[Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].

Tan WY, Hu DS, Zeng FY, Song QB, Hu S, Wei L, Zhou LQ.

Ai Zheng. 2007 Dec;26(12):1360-4. Chinese.

PMID:
18076802
19.

Incidence of second cancers in patients treated for Hodgkin's disease.

Boivin JF, Hutchison GB, Zauber AG, Bernstein L, Davis FG, Michel RP, Zanke B, Tan CT, Fuller LM, Mauch P, et al.

J Natl Cancer Inst. 1995 May 17;87(10):732-41.

PMID:
7563150
20.

Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study.

Doyle JJ, Neugut AI, Jacobson JS, Grann VR, Hershman DL.

J Clin Oncol. 2005 Dec 1;23(34):8597-605.

PMID:
16314622

Supplemental Content

Support Center